The largest database of trusted experimental protocols

2 protocols using anti ps6k thr389

1

Multiplex Flow Cytometry of Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM cells were collected from tibias and femurs and stained with anti-c-kit PE-Cy7 (BD Biosciences), anti-Sca-1 APC-Cy7 (BD Biosciences), anti-lineage V450 (BD Biosciences), anti-CD48 FITC (Biolegend), anti-CD127 FITC (BD Biosciences), anti-CD41 Alexa Fluor 488 (Biolegend), anti-CD34 APC (BD Biosciences), anti-CD135 PE (BD Biosciences), anti-CD16/32 PerCP (BD Biosciences) and anti-CD150 Alexa Fluor 647 (Biolegend). BM HSCs (CD150+CD48-Lineage-Sca-1+c-Kit+), MPPs (CD150-CD48-Lineage-Sca-1+c-Kit+), CMPs (CD34+CD16/32lowCD127-Lineage-Sca-1-c-Kit+), GMPs (CD34+CD16/32highCD127-Lineage-Sca-1-c-Kit+), MEPs (CD34-CD16/32-/lowCD127-Lineage-Sca-1-c-Kit+), MkPs (CD150+CD41+Lineage-Sca-1-c-Kit+) and EPs (CD71+Ter119+) were stained with the indicated cell surface marker antibodies. For intracellular phosphoprotein analysis, BM cells were flushed into serum-free PBS. BM cells were stained with surface marker antibodies, then washed with PBS and fixed for 15 minutes at 4°C, followed by incubation with BD c ytoperm buffer for 30 minutes at room temperature. Rabbit anti-pS6K (Thr389) (Cell Signaling Technology) or anti-pAkt PE (Cell Signaling Technology) were added at 1:50 dilution for 30 minutes. For pS6K staining, cells were incubated with anti-rabbit IgG PE (Cell Signaling Technology) at 1:500 for 30 minutes. Flow cytometric analysis was performed on a FACS CANTO II (BD Biosciences).
+ Open protocol
+ Expand
2

Thymoquinone Induces Autophagy via AMPK-mTOR Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thymoquinone was obtained from Sigma‐Aldrich (St. Louis, MO, USA) and dissolved in DMSO at a final concentration of 40 μmol/L as a stock solution. Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA, USA). Protease inhibitor and phosphatase inhibitor were obtained from Roche (Basel, Switzerland). The following primary antibodies were used in this study: anti‐β‐actin, anti‐E‐cadherin, anti‐N‐cadherin, anti‐vimentin, anti‐LC3‐I/II, anti‐AMPK, anti‐p‐AMPK (Thr172), anti‐mTOR, anti‐p‐mTOR (Ser2448) and anti‐p‐S6K (Thr389), purchased from Cell Signal Technology (Boston, MA, USA). Anti‐mouse (CWBIO, Beijing, China) and anti‐rabbit antibodies (CWBIO, Beijing, China) were used as secondary antibodies. The mRFP‐EGFP‐LC3 reporter plasmid was a gift from Tamotsu Yoshimori (Addgene plasmid # 21074).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!